74th Day Of Lockdown

Maharashtra80229286942849 Tamil Nadu2869415762235 Delhi2633410315708 Gujarat19119130111190 Rajasthan100847359218 Uttar Pradesh97335648257 Madhya Pradesh89965878384 West Bengal73032912366 Karnataka4835169357 Bihar4598223329 Andhra Pradesh4250256573 Haryana3597120924 Telangana32901627113 Jammu and Kashmir3142104835 Odisha247814819 Punjab2415204347 Assam19894434 Kerala170071215 Uttarakhand115328610 Jharkhand7642975 Chhatisgarh6781892 Tripura6221730 Himachal Pradesh3691636 Chandigarh3022225 Goa126570 Manipur124110 Puducherry90330 Nagaland8000 Arunachal Pradesh3710 Meghalaya33131 Mizoram1710 Sikkim200
Lifestyle Environment 25 Feb 2019 Pharma residue cause ...

Pharma residue cause increased ecological damage

Published Feb 25, 2019, 10:18 am IST
Updated Feb 25, 2019, 10:19 am IST
Pharmaceutical residues in global fresh water sources pose environmental risk.
The increased human use of ciprofloxacin was found to have a particularly high impact globally. (Photo: Representational/Pixabay)
 The increased human use of ciprofloxacin was found to have a particularly high impact globally. (Photo: Representational/Pixabay)

Washington: A new research now finds that over the past two decades, concentrations of pharmaceuticals have increased in freshwater sources all over the world.

According to the research by environmental experts at Radboud University, levels of the antibiotic ciprofloxacin have reached the point of potentially damaging ecological effects. The research is the first to examine the risks of two particular medicines in global freshwater sources, and is being published in Environmental Research Letters.


Speaking about it, lead author Rik Oldenkamp said, “Getting an accurate picture of the environmental risks of pharmaceuticals around the world depends on the availability of data, which is limited," adding, "It's true that there are models, such as the ePiE model, which can give detailed predictions of pharmaceutical concentrations in the environment, but these are often only applicable to places where we already have a lot of information, such as rivers in Europe."

The new model developed by the researchers, which builds on an existing model with a lower resolution, makes it possible to come up with worldwide predictions for individual ecoregions. For the two pharmaceuticals investigated in the study - carbamazepine, an anti-epileptic drug, and ciprofloxacin, an antibiotic - the environmental risks were found to be 10 to 20 times higher in 2015 than in 1995.

The increased human use of ciprofloxacin was found to have a particularly high impact globally. "The concentrations of this antibiotic can be harmful for bacteria in the water, and these bacteria in turn play an important role in various nutrient cycles," said Oldenkamp, adding, "Antibiotics can also have a negative impact on the effectiveness of bacteria colonies used in wastewater treatment."

"Our model predicts a relatively high environmental risk for ecoregions in densely populated and dry areas such as the Middle East, yet those are precisely the areas where there is little data on pharmaceutical use and concentrations in surface waters," said Oldenkamp.

The researchers predicted human pharmaceutical consumption in these areas using regression models based on consumption in other countries, along with socio-economic and demographic information, and linked this to information related to other factors such as water sources and the number of people with access to wastewater treatment.

According to Oldenkamp, the model shows a particular need for new data in those types of areas. "The model is really a starting point for creating an insight into the environmental risks posed by pharmaceuticals all over the world,” said Oldenkamp